Loading clinical trials...
Loading clinical trials...
Use of Omalizumab in the Treatment of Food Allergy and Anaphylaxis - A Multicenter Retrospective Analysis
Conditions
Locations
1
United States
Novartis
East Hanover, New Jersey, United States
Start Date
June 1, 2023
Primary Completion Date
September 1, 2023
Completion Date
September 1, 2023
Last Updated
June 18, 2025
NCT06406114
NCT05695261
NCT04653324
NCT00719719
NCT00852943
NCT07501325
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions